排序方式: 共有3条查询结果,搜索用时 0 毫秒
1
1.
T. Vromen R. W. M. Brouwers H. T. Jorstad R. A. Kraaijenhagen R. F. Spee M. E. Wittekoek M. J. Cramer J. M. C. van Hal L. Hofstra P. M. J. C. Kuijpers E. C. de Melker S. F. Rodrigo M. Sunamura N. H. M. K. Uszko-Lencer H. M. Kemps 《Netherlands heart journal》2021,29(10):479
Cardiac rehabilitation (CR) has evolved as an important part of the treatment of patients with cardiovascular disease. However, to date, its full potential is fairly underutilised. This review discusses new developments in CR aimed at improving participation rates and long-term effectiveness in the general cardiac population. It consecutively highlights new or challenging target groups, new delivery modes and new care pathways for CR programmes. These new or challenging target groups include patients with atrial fibrillation, obesity and cardiovascular disease, chronic coronary syndromes, (advanced) chronic heart failure with or without intracardiac devices, women and frail elderly patients. Also, the current evidence regarding cardiac telerehabilitation and loyalty programmes is discussed as new delivery modes for CR. Finally, this paper discusses novel care pathways with the integration of CR in residual risk management and transmural care pathways. These new developments can help to make optimal use of the benefits of CR. Therefore we should seize the opportunities to reshape current CR programmes, broaden their applicability and incorporate them into or combine them with other cardiovascular care programmes/pathways. 相似文献
2.
Brouwers R. W. M. van Exel H. J. van Hal J. M. C. Jorstad H. T. de Kluiver E. P. Kraaijenhagen R. A. Kuijpers P. M. J. C. van der Linde M. R. Spee R. F. Sunamura M. Uszko-Lencer N. H. M. K. Vromen T. Wittekoek M. E. Kemps H. M. C. 《Netherlands heart journal》2020,28(9):443-451
Netherlands Heart Journal - Multidisciplinary cardiac rehabilitation (CR) reduces morbidity and mortality and increases quality of life in cardiac patients. However, CR utilisation rates are low,... 相似文献
3.
S. Bektas F. M. E. Franssen V. van Empel N. Uszko-Lencer J. Boyne C. Knackstedt H. P. Brunner-La Rocca 《Netherlands heart journal》2017,25(5):335-342
Background
Comorbidities are common in chronic heart failure (HF) patients, but diagnoses are often not based on objective testing. Chronic obstructive pulmonary disease (COPD) is an important comorbidity and often neglected because of shared symptoms and risk factors. Precise prevalence and consequences are not well known. Therefore, we investigated prevalence, pulmonary treatment, symptoms and quality of life (QOL) of COPD in patients with chronic HF.Methods
205 patients with stable HF for at least 1 month, aged above 50 years, were included from our outpatient cardiology clinic, irrespective of left ventricular ejection fraction. Patients performed post-bronchodilator spirometry, a six-minute walk test (6-MWT) and completed the Kansas City Cardiomyopathy Questionnaire (KCCQ). COPD was diagnosed according to GOLD criteria. Restrictive lung function was defined as FEV1/FVC ≥0.70 and FVC <80% of predicted value. The BODE and ADO index, risk scores in COPD patients, were calculated.Results
Almost 40% fulfilled the criteria of COPD and 7% had restrictive lung disease, the latter being excluded from further analysis. Noteworthy, 63% of the COPD patients were undiagnosed and 8% of those without COPD used inhalation therapy. Patients with COPD had more shortness of breath despite little difference in HF severity and similar other comorbidities. KCCQ was significantly worse in COPD patients. The ADO and BODE indices were significantly different.Conclusion
COPD is very common in unselected HF patients. It was often not diagnosed and many patients received treatment without being diagnosed with COPD. Presence of COPD worsens symptoms and negatively effects cardiac specific QOL.
1